Table 6

5-FU				LV
5-FU	S. D.	% CV	%Accuracy	LV	S. D.	% CV	% Accuracy
5-FU, API High Conc. (500 ng ml^-1)				LV, API High Conc. (1000 ng ml^-1)
5-FU, API High Conc. (500 ng ml^-1)	0.6438	0.1291	99.72	LV, API High Conc. (1000 ng ml^-1)	0.8588	0.0861	99.793
Medium Conc. (12.5 ng ml^-1)	0.2692	2.185	98.563	Medium Conc. (25 ng ml^-1)	0.3678	1.4974	98.251
Utoral, 250 mg injection High Conc. (500 ng ml^-1)				Kyunrine, 15 mg injection High Conc. (1000 ng ml^-1)
Utoral, 250 mg injection High Conc. (500 ng ml^-1)	0.7982	0.1601	99.719	Kyunrine, 15 mg injection High Conc. (1000 ng ml^-1)	0.8728	0.0874	99.813
Medium Conc. (12.5 ng ml^-1)	0.2928	2.385	98.195	Medium Conc. (25 ng ml^-1)	0.3750	1.5393	97.444
5-FU in spiked plasma High Conc. (500 ng ml^-1)				LV in spiked plasma High Conc. (1000 ng ml^-1)
5-FU in spiked plasma High Conc. (500 ng ml^-1)	0.9383	0.1888	99.401	LV in spiked plasma High Conc. (1000 ng ml^-1)	1.130	0.1133	99.752
Medium Conc. (12.5 ng ml^-1)	0.0382	0.308	99.351	Medium Conc. (25 ng ml^-1)	0.3784	1.5373	98.462

Table 6: Stability data of 5-FU & LV APIs and pharmaceutical dosage forms in mobile phase and in spiked plasma.